Scientific Commons: Bernard M. Flynn

A Classical Parallel Line Interlot Potency Comparison of Lots 10 and 15 of Rift Valley Fever Vaccine in an Animal Model. (1998)

Powell, Nathaniel, Flynn, Bernard M., Mangiafico, Joseph P., Nelson, Gene O., Meadors, Gilcin F., III

Twenty lots of an improved formalin-inactivated Rift Valley fever vaccine were prepared in 1978-1979 with well-characterized, diploid fetal rhesus lung cells. Human tests of this new vaccine revealed...

Containment of Simian Immunodeficiency Virus Infection: Cellular Immune Responses and Protection from Rechallenge following Transient Postinoculation Antiretroviral Treatment

Lifson, Jeffrey D., Rossio, Jeffrey L., Arnaout, Ramy, Li, Li, Parks, Thomas L., Schneider, Douglas K., ...

To better understand the viral and host factors involved in the establishment of persistent productive infection by primate lentiviruses, we varied the time of initiation and duration of...

Protection of Macaca nemestrina from Disease following Pathogenic Simian Immunodeficiency Virus (SIV) Challenge: Utilization of SIV Nucleocapsid Mutant DNA Vaccines with and without an SIV Protein Boost

Gorelick, Robert J., Benveniste, Raoul E., Lifson, Jeffrey D., Yovandich, Jason L., Morton, William R., Kuller, LaRene, ...

Molecular clones were constructed that express nucleocapsid (NC) deletion mutant simian immunodeficiency viruses (SIVs) that are replication defective but capable of completing virtually all of the...

Role of CD8+ Lymphocytes in Control of Simian Immunodeficiency Virus Infection and Resistance to Rechallenge after Transient Early Antiretroviral Treatment†

Lifson, Jeffrey D., Rossio, Jeffrey L., Piatak, Michael, Parks, Thomas, Li, Li, Kiser, Rebecca, ...

Transient antiretroviral treatment with tenofovir, (R)-9-(2-phosphonylmethoxypropyl)adenine, begun shortly after inoculation of rhesus macaques with the highly pathogenic simian immunodeficiency...